{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:13:37Z","timestamp":1742912017348,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":33,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071637210"},{"type":"electronic","value":"9781071637227"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3722-7_20","type":"book-chapter","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:02:12Z","timestamp":1715947332000},"page":"307-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibody Isolation in C. neoformans"],"prefix":"10.1007","author":[{"given":"Susana Ruiz","family":"Mendoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"da Silva Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele Ramos","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan Jefferson","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","volume":"30","author":"EK Maziarz","year":"2016","unstructured":"Maziarz EK, Perfect JR (2016) Cryptococcosis. Infect Dis Clin N Am 30:179\u2013206. https:\/\/doi.org\/10.1016\/j.idc.2015.10.006","journal-title":"Infect Dis Clin N Am"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12281-013-0165-7","volume":"8","author":"MK Mansour","year":"2014","unstructured":"Mansour MK, Reedy JL, Tam JM et al (2014) Macrophage\u2013Cryptococcus interactions: an update. Curr Fungal Infect Rep 8:109\u2013115. https:\/\/doi.org\/10.1007\/s12281-013-0165-7","journal-title":"Curr Fungal Infect Rep"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fimmu.2018.00651","volume":"9","author":"W Elsegeiny","year":"2018","unstructured":"Elsegeiny W, Marr KA, Williamson PR (2018) Immunology of cryptococcal infections: developing a rational approach to patient therapy. Front Immunol 9:651. https:\/\/doi.org\/10.3389\/fimmu.2018.00651","journal-title":"Front Immunol"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.fgb.2014.11.006","volume":"78","author":"JF Gibson","year":"2015","unstructured":"Gibson JF, Johnston SA (2015) Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis. Fungal Genet Biol 78:76\u201386. https:\/\/doi.org\/10.1016\/j.fgb.2014.11.006","journal-title":"Fungal Genet Biol"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2217\/fmb.14.132","volume":"10","author":"S Rohatgi","year":"2015","unstructured":"Rohatgi S, Pirofski L (2015) Host immunity to Cryptococcus neoformans. Future Microbiol 10:565\u2013581. https:\/\/doi.org\/10.2217\/fmb.14.132","journal-title":"Future Microbiol"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/15321819.2018.1515775","volume":"39","author":"Y Gao","year":"2018","unstructured":"Gao Y, Huang X, Zhu Y et al (2018) A brief review of monoclonal antibody technology and its representative applications in immunoassays. J Immunoass Immunochem 39:351\u2013364. https:\/\/doi.org\/10.1080\/15321819.2018.1515775","journal-title":"J Immunoass Immunochem"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G K\u00f6hler","year":"1975","unstructured":"K\u00f6hler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495\u2013497. https:\/\/doi.org\/10.1038\/256495a0","journal-title":"Nature"},{"key":"20_CR8","first-page":"244","volume":"64","author":"AJ Scheen","year":"2009","unstructured":"Scheen AJ (2009) International classification of various types of monoclonal antibodies. Rev Med Liege 64:244\u2013247","journal-title":"Rev Med Liege"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.coph.2012.08.001","volume":"12","author":"NA Buss","year":"2012","unstructured":"Buss NA, Henderson SJ, McFarlane M et al (2012) Monoclonal antibody therapeutics: history and future. Curr Opin Pharmacol 12:615\u2013622. https:\/\/doi.org\/10.1016\/j.coph.2012.08.001","journal-title":"Curr Opin Pharmacol"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1073\/pnas.81.21.6851","volume":"81","author":"SL Morrison","year":"1984","unstructured":"Morrison SL, Johnson MJ, Herzenberg LA et al (1984) Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A 81:6851\u20136855. https:\/\/doi.org\/10.1073\/pnas.81.21.6851","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/321522a0","volume":"321","author":"PT Jones","year":"1986","unstructured":"Jones PT, Dear PH, Foote J et al (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321:522\u2013525. https:\/\/doi.org\/10.1038\/321522a0","journal-title":"Nature"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"d136","DOI":"10.2741\/A270","volume":"3","author":"M Feldmesser","year":"1998","unstructured":"Feldmesser M (1998) Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection. Front Biosci 3:d136\u2013d151. https:\/\/doi.org\/10.2741\/A270","journal-title":"Front Biosci"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","volume":"11","author":"A Casadevall","year":"2012","unstructured":"Casadevall A, Pirofski L (2012) Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe 11:447\u2013456. https:\/\/doi.org\/10.1016\/j.chom.2012.04.004","journal-title":"Cell Host Microbe"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1128\/IAI.72.8.4810-4818.2004","volume":"72","author":"RW Maitta","year":"2004","unstructured":"Maitta RW, Datta K, Chang Q et al (2004) Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles. Infect Immun 72:4810\u20134818. https:\/\/doi.org\/10.1128\/IAI.72.8.4810-4818.2004","journal-title":"Infect Immun"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1128\/IAI.00278-07","volume":"75","author":"A Rachini","year":"2007","unstructured":"Rachini A, Pietrella D, Lupo P et al (2007) An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect Immun 75:5085\u20135094. https:\/\/doi.org\/10.1128\/IAI.00278-07","journal-title":"Infect Immun"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1128\/IAI.69.5.3410-3412.2001","volume":"69","author":"\u00c1L Rosas","year":"2001","unstructured":"Rosas \u00c1L, Nosanchuk JD, Casadevall A (2001) Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection. Infect Immun 69:3410\u20133412. https:\/\/doi.org\/10.1128\/IAI.69.5.3410-3412.2001","journal-title":"Infect Immun"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1128\/IAI.68.12.7049-7060.2000","volume":"68","author":"ML Rodrigues","year":"2000","unstructured":"Rodrigues ML, Travassos LR, Miranda KR et al (2000) Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect Immun 68:7049\u20137060. https:\/\/doi.org\/10.1128\/IAI.68.12.7049-7060.2000","journal-title":"Infect Immun"},{"key":"20_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01181-21","volume":"65","author":"ABC Figueiredo","year":"2021","unstructured":"Figueiredo ABC, Fonseca FL, Kuczera D, Conte F de P, Arissawa M, Rodrigues ML (2021) Monoclonal antibodies against cell wall chitooligomers as accessory tools for the control of Cryptococcosis. Antimicrob Agents Chemother 65:e0118121. https:\/\/doi.org\/10.1128\/AAC.01181-21","journal-title":"Antimicrob Agents Chemother"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"12187","DOI":"10.1038\/s41598-017-12540-y","volume":"7","author":"SC Liedke","year":"2017","unstructured":"Liedke SC, Miranda DZ, Gomes KX, Gon\u00e7alves JLS, Frases S, Nosanchuk JD, Rodrigues ML, Nimrichter L, Peralta JM, Guimar\u00e3es AJ (2017) Characterization of the antifungal functions of a WGA-Fc (IgG2a) fusion protein binding to cell wall chitin oligomers. Sci Rep 7:12187. https:\/\/doi.org\/10.1038\/s41598-017-12540-y","journal-title":"Sci Rep"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"21765","DOI":"10.1038\/srep21765","volume":"6","author":"RJB Cordero","year":"2016","unstructured":"Cordero RJB, Liedke SC, de S. Ara\u00fajo GR, Martinez LR, Nimrichter L, Frases S, Peralta JM, Casadevall A, Rodrigues ML, Nosanchuk JD, Guimaraes AJ (2016) Enhanced virulence of Histoplasma capsulatum through transfer and surface incorporation of glycans from Cryptococcus neoformans during co-infection. Sci Rep 6:21765. https:\/\/doi.org\/10.1038\/srep21765","journal-title":"Sci Rep"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/infdis\/165.6.1086","volume":"165","author":"A Casadevall","year":"1992","unstructured":"Casadevall A, Mukherjee J, Devi SJN, Schneerson R, Robbins JB, Scharff MD (1992) Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis 165:1086\u20131093. https:\/\/doi.org\/10.1093\/infdis\/165.6.1086","journal-title":"J Infect Dis"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1128\/EC.00268-09","volume":"9","author":"M De Jesus","year":"2010","unstructured":"De Jesus M, Chow S-K, Cordero RJB, Frases S, Casadevall A (2010) Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable. Eukaryot Cell 9:1018\u20131028. https:\/\/doi.org\/10.1128\/EC.00268-09","journal-title":"Eukaryot Cell"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/S0140-6736(00)02356-4","volume":"355","author":"JD Nosanchuk","year":"2000","unstructured":"Nosanchuk JD, Rosas AL, Lee SC, Casadevall A (2000) Melanisation of Cryptococcus neoformans in human brain tissue. Lancet 355:2049\u20132050. https:\/\/doi.org\/10.1016\/S0140-6736(00)02356-4","journal-title":"Lancet"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"9326","DOI":"10.1038\/s41598-017-04307-2","volume":"7","author":"MG Rydahl","year":"2017","unstructured":"Rydahl MG, Kra\u010dun SK, Fangel JU, Michel G, Guillouzo A, G\u00e9nicot S, Mravec J, Harholt J, Wilkens C, Motawia MS, Svensson B, Tranquet O, Ralet M-C, J\u00f8rgensen B, Domozych DS, Willats WGT (2017) Development of novel monoclonal antibodies against starch and ulvan \u2013 implications for antibody production against polysaccharides with limited immunogenicity. Sci Rep 7:9326. https:\/\/doi.org\/10.1038\/s41598-017-04307-2","journal-title":"Sci Rep"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4939-2874-3_5","volume-title":"Carbohydrate-based vaccines","author":"F Broecker","year":"2015","unstructured":"Broecker F, Anish C, Seeberger PH (2015) Generation of monoclonal antibodies against defined oligosaccharide antigens. In: Lepenies B (ed) Carbohydrate-based vaccines. Springer, New York, pp 57\u201380"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.vaccine.2010.12.134","volume":"29","author":"S-K Chow","year":"2011","unstructured":"Chow S-K, Casadevall A (2011) Evaluation of Cryptococcus neoformans galactoxylomannan\u2013protein conjugate as vaccine candidate against murine cryptococcosis. Vaccine 29:1891\u20131898. https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.134","journal-title":"Vaccine"},{"key":"20_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.memsci.2017.02.040","volume":"531","author":"Y Feng","year":"2017","unstructured":"Feng Y, Han G, Chung T-S, Weber M, Widjojo N, Maletzko C (2017) Effects of polyethylene glycol on membrane formation and properties of hydrophilic sulfonated polyphenylenesulfone (sPPSU) membranes. J Membr Sci 531:27\u201335. https:\/\/doi.org\/10.1016\/j.memsci.2017.02.040","journal-title":"J Membr Sci"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"pdb.prot103176","DOI":"10.1101\/pdb.prot103176","volume":"2018","author":"EA Greenfield","year":"2018","unstructured":"Greenfield EA (2018) Polyethylene glycol fusion for hybridoma production. Cold Spring Harb Protoc 2018:pdb.prot103176. https:\/\/doi.org\/10.1101\/pdb.prot103176","journal-title":"Cold Spring Harb Protoc"},{"key":"20_CR29","doi-asserted-by":"publisher","unstructured":"Fuss IJ, Kanof ME, Smith PD, Zola H (2009) Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol 85. https:\/\/doi.org\/10.1002\/0471142735.im0701s85","DOI":"10.1002\/0471142735.im0701s85"},{"key":"20_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C, Chai X, He R, Li X, Lv Q, Zhu H, Deng W, Xu Y, Wang Y, Qiao L, Tan Y, Song L, Wang G, Du X, Gao N, Liu J, Xiao J, Su X, Du Z, Feng Y, Qin C, Qin C, Jin R, Xie XS (2020) Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells. Cell 182:73\u201384.e16. https:\/\/doi.org\/10.1016\/j.cell.2020.05.025","journal-title":"Cell"},{"key":"20_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","volume":"329","author":"T Tiller","year":"2008","unstructured":"Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, Wardemann H (2008) Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods 329:112\u2013124. https:\/\/doi.org\/10.1016\/j.jim.2007.09.017","journal-title":"J Immunol Methods"},{"key":"20_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s42003-019-0551-y","volume":"2","author":"LD Goldstein","year":"2019","unstructured":"Goldstein LD, Chen Y-JJ, Wu J, Chaudhuri S, Hsiao Y-C, Schneider K, Hoi KH, Lin Z, Guerrero S, Jaiswal BS, Stinson J, Antony A, Pahuja KB, Seshasayee D, Modrusan Z, H\u00f6tzel I, Seshagiri S (2019) Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies. Commun Biol 2:304. https:\/\/doi.org\/10.1038\/s42003-019-0551-y","journal-title":"Commun Biol"},{"key":"20_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.celrep.2019.12.063","volume":"30","author":"F Horns","year":"2020","unstructured":"Horns F, Dekker CL, Quake SR (2020) Memory B cell activation, broad anti-influenza antibodies, and bystander activation revealed by single-cell transcriptomics. Cell Rep 30:905\u2013913.e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.063","journal-title":"Cell Rep"}],"container-title":["Methods in Molecular Biology","Cryptococcus neoformans"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3722-7_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:03:38Z","timestamp":1715947418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3722-7_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071637210","9781071637227"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3722-7_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"18 May 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}